Why the study?
Does infliximab improve left ventricular ejection fraction and reduce biomarkers of heart failure in female patients with rheumatoid arthritis?
Population
23 female patients with rheumatoid arthritis resistant to treatment with disease-modifying antirheumatic…
Design
Cohort
Follow-up
1 year
Authors
Loading...
Infliximab was associated with LVEF gains and lower HF biomarkers in RA; hypothesis-generating and requires randomized confirmation before practice change.
Does infliximab improve left ventricular ejection fraction and reduce biomarkers of heart failure in female patients with rheumatoid arthritis?
Infliximab treatment in patients with rheumatoid arthritis significantly increased left ventricular ejection fraction and reduced biochemical markers of heart failure.
Kotyla et al. (2012) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: